Health Affairs, 28, no. 5 (2009): w770-w781
(Published online 21 July 2009)
doi: 10.1377/hlthaff.28.5.w770
© 2009 by Project HOPE
 
New Online
 * Getting Health Reform Done
 * After the State of the Union
 * Incremental Reform
 * E-Health in Developing World
 * Most-Read Articles in 2009
This Article
* Figures Only
* Full Text (HTML)
* Reprint (PDF)
* Appendices
* TOC
* Submit a response to this article
* Alert me when this article is cited
* Alert me when Comments are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
Google Scholar
* Articles by Crystal, S.
* Articles by Gerhard, T.
PubMed
* PubMed Citation
* Articles by Crystal, S.
* Articles by Gerhard, T.
Related Collections
* Insurance Coverage
* Legal/Regulatory Issues
* Managed Care - Mental Health
* Mental Health/Substance Abuse
* Research And Technology
* Health Spending
* Consumer Issues
* Evidence-Based Medicine
*Related Articles

Web Exclusives

Broadened Use Of Atypical Antipsychotics: Safety, Effectiveness, And Policy Challenges

Stephen Crystal, Mark Olfson, Cecilia Huang, Harold Pincus and Tobias Gerhard

Atypical antipsychotic medications are increasingly used for a wide range of clinical indications in diverse populations, including privately and publicly insured youth and elderly nursing home residents. These trends heighten policy challenges for payers, patients, and clinicians related to appropriate prescribing and management, patient safety, and clinical effectiveness. For clinicians and patients, balancing risks and benefits is challenging, given the paucity of effective alternative treatments. For health care systems, regulators, and policymakers, challenges include developing the evidence base on comparative risks and benefits; defining measures of treatment quality; and implementing policies that encourage evidence-based practices while avoiding unduly burdensome restrictions.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?

Related Articles



This article has been cited by other articles:


Home page
Arch Intern MedHome page
Y. Chen, B. A. Briesacher, T. S. Field, J. Tjia, D. T. Lau, and J. H. Gurwitz
Unexplained Variation Across US Nursing Homes in Antipsychotic Prescribing Rates
Arch Intern Med, January 11, 2010; 170(1): 89 - 95.
[Abstract] [Full Text] [PDF]